SPO Networks, Inc. (SPOI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2006 | 2005 |
|---|---|---|---|---|---|---|
| Total Assets | - | 5.74 Million | 10 Thousand | - | 5.61 Million | 8.2 Million |
| Total Current Assets | - | 3.55 Million | 10 Thousand | - | 896.58 Thousand | 933.79 Thousand |
| Cash And Short Term Investments | - | 31.61 Thousand | 10 Thousand | - | 26.43 Thousand | 66.06 Thousand |
| Cash and Cash Equivalents | - | 31.61 Thousand | 10 Thousand | - | 26.43 Thousand | 66.06 Thousand |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | 433.36 Thousand | - | - | 857.33 Thousand | 319.61 Thousand |
| Inventory | - | 3.09 Million | - | - | - | 71.58 Thousand |
| Other Current Assets | - | 1.00 | - | - | - | 476.54 Thousand |
| Total Non-Current Assets | - | 2.18 Million | - | - | 4.72 Million | 7.26 Million |
| Net PPE | - | 2.17 Million | - | - | 83.92 Thousand | 127.33 Thousand |
| Good Will And Intangible Assets | - | - | - | - | 137.05 Thousand | 2.89 Million |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | 137.05 Thousand | 2.89 Million |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | 5594.00 | - | - | 4.49 Million | 4.24 Million |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | - | 4.87 Million | 152.08 Thousand | - | 12.42 Million | 1.52 Million |
| Total Current Liabilities | - | 1 Million | 152.08 Thousand | - | 12.24 Million | 589.65 Thousand |
| Account Payables | - | 284.09 Thousand | - | - | 278.88 Thousand | 281.7 Thousand |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | 343.18 Thousand | - | - | 206.2 Thousand | 50.09 Thousand |
| Deferred Revenue | - | - | - | - | 724.44 Thousand | 15.5 Thousand |
| Other Current Liabilities | - | 375.08 Thousand | 152.08 Thousand | - | 11.76 Million | 484.69 Thousand |
| Total Non Current Liabilities | - | 3.86 Million | - | - | 172.2 Thousand | 933.7 Thousand |
| Long-Term Debt | - | 3.86 Million | - | - | 152.33 Thousand | 933.7 Thousand |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | 19.87 Thousand | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | - | 869.05 Thousand | -142.08 Thousand | 806.36 Thousand | - | - |
| Stock Holders Equity | - | 869.05 Thousand | -142.08 Thousand | 806.36 Thousand | -6.8 Million | 6.67 Million |
| Common Stock | - | 833.62 Thousand | 833.62 Thousand | 806.36 Thousand | - | 15.48 Million |
| Retained Earnings | - | 296.6 Thousand | -923.55 Thousand | -922.55 Thousand | -16.42 Million | -8.8 Million |
| Accumulated other comprehensive income | - | -833.62 Thousand | -833.61 Thousand | - | -248.71 Thousand | - |
| Common Stock Equity | - | 869.05 Thousand | -142.08 Thousand | 806.36 Thousand | -6.8 Million | 6.67 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | - | 4.21 Million | - | - | 358.53 Thousand | 983.8 Thousand |
| Net Debt | - | 4.18 Million | -10 Thousand | - | 332.09 Thousand | 917.74 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Total Assets | - | - | 7.08 Million | - | 6.93 Million | 6.26 Million |
| Total Current Assets | - | - | 5.33 Million | - | 4.88 Million | 4.2 Million |
| Cash And Short Term Investments | - | - | 1.54 Million | - | 835.31 Thousand | 27.18 Thousand |
| Cash and Cash Equivalents | - | - | 1.54 Million | - | 835.31 Thousand | 27.18 Thousand |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | 49.72 Thousand | - | 317.1 Thousand | 420.86 Thousand |
| Inventory | - | - | 3.49 Million | - | 3.49 Million | 3.53 Million |
| Other Current Assets | - | - | 245.98 Thousand | - | 234.18 Thousand | 228.08 Thousand |
| Total Non-Current Assets | - | - | 1.75 Million | - | 2.05 Million | 2.05 Million |
| Net PPE | - | - | 1.75 Million | - | 2.05 Million | 2.05 Million |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | -1.00 | - | -1.00 | -1.00 |
| Other Assets | - | - | 1.00 | - | - | - |
| Total Liabilities | - | - | 9.07 Million | - | 9.33 Million | 9.57 Million |
| Total Current Liabilities | - | - | 736.48 Thousand | - | 866.93 Thousand | 1.02 Million |
| Account Payables | - | - | 169.69 Thousand | - | 289.03 Thousand | 304.34 Thousand |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | - | 386.62 Thousand | - | 386.62 Thousand | 387.83 Thousand |
| Deferred Revenue | - | - | - | - | 1.00 | - |
| Other Current Liabilities | - | - | 180.17 Thousand | - | 191.27 Thousand | 330.88 Thousand |
| Total Non Current Liabilities | - | - | 8.33 Million | - | 8.46 Million | 8.55 Million |
| Long-Term Debt | - | - | 8.33 Million | - | 8.46 Million | 8.55 Million |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | - | - | 1.00 | - | - | - |
| Total Equity | - | - | -1.98 Million | - | -2.39 Million | -3.31 Million |
| Stock Holders Equity | - | - | -1.98 Million | - | -2.39 Million | -3.31 Million |
| Common Stock | - | - | 437.00 | - | 437.00 | 437.00 |
| Retained Earnings | - | - | -2.16 Million | - | -2.57 Million | -3.48 Million |
| Accumulated other comprehensive income | - | - | -436.00 | - | -437.00 | -437.00 |
| Common Stock Equity | - | - | -1.98 Million | - | -2.39 Million | -3.31 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | - | - | 8.72 Million | - | 8.85 Million | 8.94 Million |
| Net Debt | - | - | 7.18 Million | - | 8.01 Million | 8.91 Million |
SLSDF
CARCY
FESA3
DIABIO
GENPHARMA
GATE